Flexibility
Get exactly the panel you want. More than 90% of ProcartaPlex assays can be combined with one another and allow for the creation of highly individual and high-plex panels (≤ 80-plex).
Reproducible results
Each ProcartaPlex assay is manufactured in an ISO 9001 certified facility and undergoes rigorous QC testing to help ensure reproducibility and lot-to-lot consistency.
Scalability
Achieve reproducible performances regardless of plex size and correlate data from differently sized panels and simplex kits.
High specificity and sensitivity
All ProcartaPlex assays are extensively and individually tested for specificity and detection of native endogenous protein as well as for combinability, interference, and cross-reactivity.
Save resources
ProcartaPlex multiplexing assays require smaller sample input and less hands-on time than single-analyte assays, helping reduce time to results, cost and labor.
Free analysis software
ProcartaPlex Analyst App is free software available through Thermo Fisher Connect with 1 TB of cloud storage at no charge.
All preconfigured multi-analyte reagent panels are extensively tested for combinability, interference, and cross-reactivity and go through stringent quality control standards.
Specification |
Description |
Specificity |
Proof of endogenous, native protein detection in specific samples |
Sensitivity |
Detection of relevant native protein levels |
Precision |
Inter-assay CV: <15%, Intra-assay CV: <15% |
Linearity of dilution |
Linear results over the range of the assay |
Lot-to-lot consistency |
Each new batch is calibrated against the reference standard lot |
Dynamic range |
Large dynamic range of all ProcartaPlex assays |
Table 1. Cross-reactivity testing of analytes in ProcartaPlex preconfigured panels. Only a small subset of analytes are shown here.
Figure 1. Scalability data to demonstrate reproducibility between ProcartaPlex panels of different size. Comparison of protein expression data from 42 human blood samples analyzed using the ProcartaPlex Human Immune Monitoring Panel, 65-Plex and the ProcartaPlex Human Immune Response Panel, 80-Plex. A selection of analytes is shown here. Similar results are obtained when investigating other analytes.
Figure 2. Data illustrates the high correlation between large and small-scale multiplex assays when using the ProcartaPlex assays. Regression analysis comparing the ProcartaPlex Chemokine Panel 2 (9-plex) and the ProcartaPlex Human Immune Response Panel, Immune Response Panel (80-plex) yielded an R2 value >0.9. (0.99 for MCP-4, 0.93 for CCL1)
For Research Use Only. Not for use in diagnostic procedures.